---
title: "The chemical and chemical engineering sector surged, with DHCT and GPTY hitting the daily limit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/239026401.md"
description: "The chemical and chemical engineering sector surged, with DHCT and GPTY hitting the daily limit, Zhongyida rising over 8%, and Huiyun Titanium and Jiangtian Chemical following suit"
datetime: "2025-05-07T02:19:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/239026401.md)
  - [en](https://longbridge.com/en/news/239026401.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/239026401.md)
generator: "portal-rs"
---

# The chemical and chemical engineering sector surged, with DHCT and GPTY hitting the daily limit

The chemical and chemical engineering sector surged, with DHCT and GPTY hitting the daily limit, Zhongyida rising over 8%, and Huayun Titanium and Jiangtian Chemical following suit

### Related Stocks

- [600844.CN](https://longbridge.com/en/quote/600844.CN.md)
- [000545.CN](https://longbridge.com/en/quote/000545.CN.md)
- [600610.CN](https://longbridge.com/en/quote/600610.CN.md)
- [300891.CN](https://longbridge.com/en/quote/300891.CN.md)
- [300927.CN](https://longbridge.com/en/quote/300927.CN.md)
- [900921.CN](https://longbridge.com/en/quote/900921.CN.md)

## Related News & Research

- [Rainier Acquisition director Jonas Grossman acquires $56,250 in common shares](https://longbridge.com/en/news/297826326.md)
- [CLS sets private placement of 259,208 units at SEK 7.6 each to Vator Securities](https://longbridge.com/en/news/297947534.md)
- [CLS issues 777,624 warrants in directed placement at SEK 1.9 exercise price](https://longbridge.com/en/news/297947522.md)
- [Xiaomi builds dealer network for German market entry](https://longbridge.com/en/news/298020009.md)
- [02:00 ETArgo Biopharma to Present Positive Phase II Updated Results of siRNA Therapeutic BW-20805 for HAE at Bradykinin Symposium 2026](https://longbridge.com/en/news/297995914.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**